NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

TD Cowen Boosts TransMedics Price Target to $120 on Strong Transplant Growth

Accelerating U.S. heart, liver & lung transplants plus strong flight data signal major growth ahead.

TD Cowen Boosts TransMedics Price Target to $120 on Strong Transplant Growth
Credit: PRNewswire/TransMedics
Already have an account? Sign in.
07/01/2026 · 3:38 PM
TMDX
/ Don’t stop at just one post.

Related↓

Why TransMedics Stock Fell — and Why Analysts Aren’t Worried
01/21/2026 · 3:34 PM

Why TransMedics Stock Fell — and Why Analysts Aren’t Worried

TransMedics shares dropped after FDA clearance of a rival liver perfusion system, but TD Cowen says the selloff is overdone and sees no real competitive threat.

/ Subscriber only
/ Read more

Feed↓

GameStop Cuts Open-Ended Dilution Risk After Preliminary Q2 Results
08/31/2026 · 6:56 AM

GameStop Cuts Open-Ended Dilution Risk After Preliminary Q2 Results

GameStop shortens the VWAP window, sets a fixed 55.5M-share package, and guides Q2 sales above thin estimates with much higher operating profit.

/ Subscriber only
California Wildfire Bill Falls Short, Banks Cut PG&E, Edison and Sempra
Featured/ 08/31/2026 · 6:18 AM

California utilities get cut by Wall Street after a weak wildfire bill

Lawmakers advanced a narrower SB 492. BMO, Mizuho and Wells Fargo cut PG&E, Edison and Sempra over unfixed wildfire risk.

/ Subscriber only
BioMarin Stock Jumps After Settling Yuviwel Patent Fight With Ascendis
08/31/2026 · 5:33 AM

BioMarin Stock Jumps After Settling Yuviwel Patent Fight With Ascendis

BioMarin and Ascendis end all Yuviwel patent fights. Ascendis will pay 20% on U.S. sales and 18% in the EU, Brazil, and South Korea until 2030.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe